A Test for Multiple Binary Endpoints with Continuous Latent Distribution in Clinical Trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2214-1766
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A Test for Multiple Binary Endpoints with Continuous Latent Distribution in Clinical Trials ; volume:20 ; number:4 ; day:13 ; month:10 ; year:2021 ; pages:463-480 ; date:12.2021
Journal of Statistical Theory and Applications ; 20, Heft 4 (13.10.2021), 463-480, 12.2021
- Creator
-
Ishihara, Takuma
Yamamoto, Kouji
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s44199-021-00003-3
- URN
-
urn:nbn:de:101:1-2022020607461317431979
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ishihara, Takuma
- Yamamoto, Kouji
- SpringerLink (Online service)
Other Objects (12)
A retrospective analysis of conditional power assumptions in clinical trials with continuous or binary endpoints
Internal pilot study design in clinical trials with multiple binary endpoints
Optimal futility stopping boundaries for binary endpoints
Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints
Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
The Bayesian Group-Sequential Predictive Evidence Value Design for Phase II Clinical Trials with Binary Endpoints
Endpoints for clinical trials in retinal diseases
A Bayesian semiparametric latent variable model for binary, ordinal and continuous response
Interim analysis incorporating short‐ and long‐term binary endpoints
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
A retrospective analysis of conditional power assumptions in clinical trials with continuous or binary endpoints
Internal pilot study design in clinical trials with multiple binary endpoints
Optimal futility stopping boundaries for binary endpoints
Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints
Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
The Bayesian Group-Sequential Predictive Evidence Value Design for Phase II Clinical Trials with Binary Endpoints
Endpoints for clinical trials in retinal diseases
A Bayesian semiparametric latent variable model for binary, ordinal and continuous response
Interim analysis incorporating short‐ and long‐term binary endpoints
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
A retrospective analysis of conditional power assumptions in clinical trials with continuous or binary endpoints
Internal pilot study design in clinical trials with multiple binary endpoints
Optimal futility stopping boundaries for binary endpoints
Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints
Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
The Bayesian Group-Sequential Predictive Evidence Value Design for Phase II Clinical Trials with Binary Endpoints
Endpoints for clinical trials in retinal diseases
A Bayesian semiparametric latent variable model for binary, ordinal and continuous response
Interim analysis incorporating short‐ and long‐term binary endpoints
Efficacy Endpoints in Clinical Trials in Actinic Keratosis